Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Jing Huang

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Journal of Medical Economics|October 10, 2019
Value of clinical trial narrative data to estimate the costs of adverse event management: a feasibility studyDeirdre Mladsi, Lisa M Hess, Christine L Barnett, et al.
Chinese Medical Journal|March 18, 2006
Sequence variability of human cytomegalovirus UL143 in low-passage clinical isolatesRong He, Qiang Ruan, Ying Qi, et al.
Intervirology|February 24, 2006
Sequence variability of human cytomegalovirus UL146 and UL147 genes in low-passage clinical isolatesRong He, Qiang Ruan, Ying Qi, et al.
Journal of Virological Methods|September 20, 2005
Structure and variability of the UL149 open reading frame from low-passage clinical isolates of human cytomegalovirusYao-hua Ji, Qiang Ruan, Zheng-rong Sun, et al.
Plos One|June 8, 2011
Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapyMing Yin, Zhongxing Liao, Yu-Jing Huang, et al.
Breast Cancer Research and Treatment|November 22, 2022
Patient characteristics, treatment patterns, and outcomes of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer patients prescribed cyclin-dependent kinase 4 and 6 inhibitors: large-scale data analysis using a Japanese claims databaseMasaaki Kawai, Masahiro Takada, Takahiro Nakayama, et al.
Carcinogenesis|October 12, 2010
A novel functional DEC1 promoter polymorphism -249T>C reduces risk of squamous cell carcinoma of the head and neckYu-Jing Huang, Jiangong Niu, Sheng Wei, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 11, 2011
Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancerChan H Han, Yu-Jing Huang, Karen H Lu, et al.
Chinese Medical Journal|June 18, 2019
Identification and characterization of a novel group of natural anti-sense transcripts from RNA1.2 gene locus of human cytomegalovirusBing-Yang Liu, Yan-Ping Ma, Ying Qi, et al.
Journal of Drug Targeting|May 19, 2025
Revisiting VEGF/VEGFR-2 signalling as an anticancer target and its inhibitor discovery: where are we and where should we go?Sheng-Xin Yao, Yu-Jing Huang, Yue-Xi Zhang, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Journal of Medical Economics|October 10, 2019
Value of clinical trial narrative data to estimate the costs of adverse event management: a feasibility studyDeirdre Mladsi, Lisa M Hess, Christine L Barnett, et al.
Chinese Medical Journal|March 18, 2006
Sequence variability of human cytomegalovirus UL143 in low-passage clinical isolatesRong He, Qiang Ruan, Ying Qi, et al.
Intervirology|February 24, 2006
Sequence variability of human cytomegalovirus UL146 and UL147 genes in low-passage clinical isolatesRong He, Qiang Ruan, Ying Qi, et al.
Journal of Virological Methods|September 20, 2005
Structure and variability of the UL149 open reading frame from low-passage clinical isolates of human cytomegalovirusYao-hua Ji, Qiang Ruan, Zheng-rong Sun, et al.
Plos One|June 8, 2011
Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapyMing Yin, Zhongxing Liao, Yu-Jing Huang, et al.
Breast Cancer Research and Treatment|November 22, 2022
Patient characteristics, treatment patterns, and outcomes of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer patients prescribed cyclin-dependent kinase 4 and 6 inhibitors: large-scale data analysis using a Japanese claims databaseMasaaki Kawai, Masahiro Takada, Takahiro Nakayama, et al.
Carcinogenesis|October 12, 2010
A novel functional DEC1 promoter polymorphism -249T>C reduces risk of squamous cell carcinoma of the head and neckYu-Jing Huang, Jiangong Niu, Sheng Wei, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 11, 2011
Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancerChan H Han, Yu-Jing Huang, Karen H Lu, et al.
Chinese Medical Journal|June 18, 2019
Identification and characterization of a novel group of natural anti-sense transcripts from RNA1.2 gene locus of human cytomegalovirusBing-Yang Liu, Yan-Ping Ma, Ying Qi, et al.
Journal of Drug Targeting|May 19, 2025
Revisiting VEGF/VEGFR-2 signalling as an anticancer target and its inhibitor discovery: where are we and where should we go?Sheng-Xin Yao, Yu-Jing Huang, Yue-Xi Zhang, et al.
Pageof 7